Most Recent
The maker of the popular Maxi-Cosi line of child car seats has lost its opposition to a rival's patent for a child car seat designed to reduce the risk of the safety tether breaking in a crash.
Dozens of media organisations worldwide have joined forces in a letter to Prime Minister Anthony Albanese, slamming proposals to amend copyright laws to allow an exemption for AI companies.
A songwriter who is suing Universal Music over royalties has dodged the music company's bid for $150,000 in security, with a judge finding the artist's claim that he could release an album to fund the litigation amounted to "puffery".
US-based medical device maker OrthAlign has lost its lawsuit alleging Sydney-based surgical technology company Navbit infringed its patent for a technology used to guide the positioning of artificial hip joints during surgery.
Swiss drug companies Actelion and J&J's Janssen-Cilag have brought litigation against three generics makers over their plans to launch cheaper versions of two blood pressure medications.
a2 Milk Company is challenging a decision that found a Victorian farmer's preparatory steps to selling products under a 23-year-old trade mark incorporating the 'A2' symbol met the bar for establishing use of the mark.
IP Australia has ruled in favour of supplement maker Nature’s Way, finding that the registration of a Chinese competitor’s ‘Nature’s Bay’ trade mark was likely to cause consumer confusion.
A Sydney-based spice wholesaler has lost its bid to register a trade mark containing the word 'Tadka', with a delegate finding the word describes an Indian cooking technique.
AstraZeneca has attacked generic drugmaker Pharmacor’s challenge to a patent extension for its diabetes drug Forxiga, telling a judge that it hinges on the false notion that the protected IP is limited to a single molecule.
Target has lodged an appeal after an IP Australia delegate rejected its opposition to a e-commerce merchandise importer's bid to register a diagonal arrow as a trade mark.